Antiarrhythmic Drug Classes
The Vaughan-Williams classification of antiarrhythmic drugs, their electrophysiological mechanisms, and clinical applications.
## Overview
The Vaughan-Williams classification organizes antiarrhythmic drugs by their primary electrophysiological effect on cardiac ion channels and receptors. While imperfect, it remains the most widely used framework. All antiarrhythmic drugs carry proarrhythmic risk, meaning they can paradoxically worsen or create new arrhythmias.
## Class I: Sodium Channel Blockers
Class I agents block voltage-gated sodium channels, slowing phase 0 depolarization and conduction velocity.
- **Class IA** (procainamide, quinidine, disopyramide): Moderate sodium channel blockade with potassium channel inhibition. Prolong action potential duration and QT interval. Used for atrial fibrillation and ventricular arrhythmias. Risk of torsades de pointes.
- **Class IB** (lidocaine, mexiletine): Fast-binding with preferential effect on ischemic tissue. Shorten action potential duration. Lidocaine is used IV for ventricular tachycardia. Minimal effect on normal tissue at therapeutic doses.
- **Class IC** (flecainide, propafenone): Potent sodium blockade with slow unbinding. Markedly slow conduction. Highly effective for atrial fibrillation in structurally normal hearts. Contraindicated after myocardial infarction (CAST trial showed increased mortality).
## Class II: Beta-Blockers
Beta-blockers suppress automaticity and prolong AV nodal conduction by blocking sympathetic stimulation. They are the safest antiarrhythmics overall and reduce sudden cardiac death in post-MI and heart failure patients. Metoprolol, atenolol, and esmolol (ultra-short IV) are commonly used for rate control.
## Class III: Potassium Channel Blockers
Amiodarone, sotalol, dofetilide, and ibutilide prolong repolarization by blocking potassium channels (primarily hERG/IKr). Amiodarone is the most broadly effective antiarrhythmic but causes thyroid, pulmonary, hepatic, and dermatologic toxicity with chronic use. Sotalol combines class III with beta-blocking properties. Dofetilide requires in-hospital initiation with QTc and renal monitoring.
## Class IV: Calcium Channel Blockers
Verapamil and diltiazem slow conduction through the AV node by blocking L-type calcium channels. They are first-line for supraventricular tachycardias including AV nodal reentrant tachycardia. Contraindicated in wide-complex tachycardia of uncertain origin and in patients with severe LV dysfunction.
## Beyond the Classification
Adenosine (purinergic receptor agonist) terminates SVT by transiently blocking AV nodal conduction. Digoxin increases vagal tone. Ivabradine selectively inhibits funny current. These agents do not fit neatly into the Vaughan-Williams system.
## Key Takeaways
- Class I drugs block sodium channels with varying kinetics and risk profiles
- Beta-blockers (Class II) are the safest antiarrhythmics overall
- Amiodarone is the most effective but has significant long-term toxicity
- All antiarrhythmics carry proarrhythmic potential, especially in structural heart disease